Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy
暂无分享,去创建一个
I. Yeh | P. Bahadoran | R. Ballotti | G. Bollag | S. Rocchi | B. Bastian | P. Leboit | T. McCalmont | M. Garrido | Elizabeth A. Burton | T. Botton | Swapna S. Vemula | M. Allégra | Alyssa J. Sparatta | Tyrrell Nelson